Recalls for 03/16/2019

2020 FREIGHTLINER CASCADIA - AIR BAGS:FRONTAL
03/16/2019 Vehicle Recall

Daimler Trucks North America LLC (DTNA) is recalling certain 2018-2020 Freightliner Cascadia vehicles equipped with an optional steering wheel air bag. The driver's frontal air bag may deploy unexpectedly.

  • Company:
    FREIGHTLINER
  • Recall Number
    19V066000
2019 LAKOTA BIGHORN - EQUIPMENT:OTHER:LABELS | TIRES
03/16/2019 Vehicle Recall

Lakota Corporation (Lakota) is recalling certain 2018-2019 Lakota Bighorn, Charger, Colt and Livestock Edition trailers. The affected vehicles have incorrect tire data listed on the Federal Placard, possibly resulting in the tires being overloaded. As such, these vehicles fail to comply to with the requirements of Federal Motor Vehicle Safety Standard (FMVSS) number 110 "Tire Selection and Rims," as well as 49 CFR Part 567, "Certification."

  • Company:
    LAKOTA
  • Recall Number
    19V080000
2019 BLUE BIRD VISION - EQUIPMENT ADAPTIVE | EQUIPMENT ADAPTIVE
03/16/2019 Vehicle Recall

Blue Bird Body Company (Blue Bird) is recalling one 2019 Blue Bird Vision bus equipped with a Ricon S-Series Titanium Wheelchair lift. The wheelchair lift positioning input cam may fail while the lift is in use, allowing the platform to travel higher than the vehicle's floor height. As such, this vehicle fails to comply with the requirements of Federal Motor Vehicle Safety Standard (FMVSS) number 403, "Platform Lift Systems."

  • Company:
    BLUE BIRD
  • Recall Number
    19V081000
Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient
03/16/2019 Food Recall

Legacy Pharmaceutical Packaging, LLC is recalling 3 repackaged lots of Losartan Tablets USP 50mg to the consumer level. This recall was prompted due to Torrent Pharmaceuticals LTD issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, (API manufacturer).